Agency Information Collection Activities: Fast Track Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery: IHS Web Site Customer Service Satisfaction Survey, 1697-1699 [2012-396]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 7 / Wednesday, January 11, 2012 / Notices
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Yvette
Waples at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at:
https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm111462.htm for
procedures on public conduct during
advisory committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: January 5, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012–324 Filed 1–10–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Arthritis Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
pmangrum on DSK3VPTVN1PROD with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Arthritis
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on March 12, 2012, from 8 a.m. to
5:30 p.m.
Location: FDA White Oak Campus,
10903 New Hampshire Ave., Building
31 Conference Center, the Great Room,
(rm. 1503), Silver Spring, MD 20993–
0002. Information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/default.htm; under
the heading ‘‘Resources for You,’’ click
on ‘‘Public Meetings at the FDA White
Oak Campus.’’ Please note that visitors
to the White Oak Campus must enter
through Building 1.
Contact Person: Philip A. Bautista,
Center for Drug Evaluation and
Research, Food and Drug
VerDate Mar<15>2010
15:02 Jan 10, 2012
Jkt 226001
Administration, 10903 New Hampshire
Ave., Bldg. 31, rm. 2417, Silver Spring,
MD 20993–0002, (301) 796–9001, FAX:
(301) 847–8533, email:
AAC@fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–(800)
741–8138 ((301) 443–0572 in the
Washington, DC area), and follow the
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
A notice in the Federal Register about
last minute modifications that impact a
previously announced advisory
committee meeting cannot always be
published quickly enough to provide
timely notice. Therefore, you should
always check the Agency’s Web site and
call the appropriate advisory committee
hot line/phone line to learn about
possible modifications before coming to
the meeting.
Agenda: The committee will discuss
the anti-nerve growth factor (Anti-NGF)
drug class that is currently under
development and the safety issues
possibly related to these drugs. These
drugs are being developed for the
treatment of a variety of chronic painful
conditions including osteoarthritis,
chronic lower back pain, diabetic
peripheral neuropathy, post-herpetic
neuralgia, chronic pancreatitis,
endometriosis, interstitial cystitis,
vertebral fracture, thermal injury, and
cancer pain. The committee will be
asked to determine whether reports of
joint destruction represent a safety
signal related to the Anti-NGF class of
drugs, and whether the risk benefit
balance for these drugs favors continued
development of the drugs as analgesics.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before February 27, 2012.
Oral presentations from the public will
be scheduled between approximately
1:30 p.m. and 2:30 p.m. Those
individuals interested in making formal
oral presentations should notify the
contact person and submit a brief
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
1697
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before February 16, 2012. Time
allotted for each presentation may be
limited. If the number of registrants
requesting to speak is greater than can
be reasonably accommodated during the
scheduled open public hearing session,
FDA may conduct a lottery to determine
the speakers for the scheduled open
public hearing session. The contact
person will notify interested persons
regarding their request to speak by
February 17, 2012.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Philip A.
Bautista at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: January 5, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012–326 Filed 1–10–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Agency Information Collection
Activities: Fast Track Generic
Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery: IHS Web Site
Customer Service Satisfaction Survey
Indian Health Service, HHS.
30-Day notice of submission of
information collection approval from
the Office of Management and Budget
(OMB) and request for comments.
AGENCY:
ACTION:
E:\FR\FM\11JAN1.SGM
11JAN1
1698
Federal Register / Vol. 77, No. 7 / Wednesday, January 11, 2012 / Notices
As part of a Federal
Government-wide effort to streamline
the process to seek feedback from the
public on service delivery, Indian
Health Service has submitted a Generic
Information Collection Request (Generic
ICR): ‘‘Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery’’ to OMB for
approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et
seq.).
DATES: Comments must be submitted by
February 10, 2012.
ADDRESSES: Send your written
comments and suggestions regarding the
proposed information collection
contained in this notice, especially
regarding the estimated public burden
and associated response time to: Office
of Management and Budget, Office of
Regulatory Affairs, Attention: Desk
Officer for IHS, New Executive Office
Building, Room 10235, Washington, DC
20503.
Send Requests for Further
Information: Requests for more
information on the proposed collection
or requests to obtain a copy of the data
collection instrument(s) and
instructions may be directed to Tamara
Clay, Acting Reports Clearance Officer,
801 Thompson Avenue, TMP, Suite 450,
Rockville, MD 20852; via non-toll free
phone (301) 443–4750; via facsimile to
(301) 443–9879; or via email to
tamara.clay@ihs.gov.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the
Collection of Qualitative Feedback on
Agency Service Delivery: IHS Web site
Customer Service Satisfaction Survey.
SUMMARY:
Abstract: The information collection
activity will garner qualitative customer
and stakeholder feedback in an efficient,
timely manner, in accordance with the
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
In the Federal Register Notice of
December 22, 2010 (75 FR 80542), OMB
published a 60-day notice requesting
public comment on the proposed
collection of information. The Agency
received zero (0) comments in response
to the 60 day notice. Below we provide
Indian Health Service’s projected
annual average estimates for the next
three years: 1
Current Actions: New collection of
Information.
Type of Review: New Collection.
Affected Public: Individuals and
Households, Businesses and
Organizations, State, Local or Tribal
Government.
Average Expected Annual Number of
Activities: 1.
Respondents: 500.
Annual Responses: 500.
Frequency of Response: Once per
request.
Average Minutes per Response:
15 minutes.
Burden Hours: 125 hours.
IHS estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN
Number of
respondents
Type of collection
Number of
responses per
respondent
Average
burden per
response
(in hours) 2
Total hours
500
1
15/60
125
Total ..........................................................................................................
pmangrum on DSK3VPTVN1PROD with NOTICES
Web site Customer satisfaction survey (web-based) ......................................
500
1
15/60
125
1 The 60-day notice included the following
estimate of the aggregate burden hours for this
generic clearance federal-wide:
Average Expected Annual Number of activities:
25,000.
VerDate Mar<15>2010
15:02 Jan 10, 2012
Jkt 226001
Average number of Respondents per Activity:
200.
Annual Responses: 5,000,000.
Frequency of Response: Once per request.
Average minutes per response: 30.
PO 00000
Frm 00034
Fmt 4703
Sfmt 9990
Burden hours: 2,500,000.
2 Burden estimates of less than one hour are
expressed as a fraction of an hour in the format
‘‘[number of minutes per response]/60’’.
E:\FR\FM\11JAN1.SGM
11JAN1
Federal Register / Vol. 77, No. 7 / Wednesday, January 11, 2012 / Notices
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
Comment Due Date: Your comments
regarding this information collection are
best assured of having full effect if
received within 30 days of the date of
this publication.
Dated: December 11, 2011.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2012–396 Filed 1–10–12; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
pmangrum on DSK3VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Council
of Councils.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Council of Councils.
Date: February 1, 2012.
Open: 8:30 a.m. to 3 p.m.
Agenda: Call to order, Overview of Office
of Research Infrastructure Program (ORIP),
Division of Program Coordination, Planning,
and Strategic Initiatives Update, and
Scientific Presentation.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 3 p.m. to 4:40 p.m.
Agenda: To review and evaluate grant
applications.
2 Burden estimates of less than one hour are
expressed as a fraction of an hour in the format
‘‘[number of minutes per response]/60’’.
VerDate Mar<15>2010
15:02 Jan 10, 2012
Jkt 226001
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Open: 4:40 p.m. to 5 p.m.
Agenda: Overall discussion and
adjournment.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Robin Kawazoe, Executive
Secretary, Division of Program Coordination,
Planning, and Strategic Initiatives, Office of
the Director, NIH, Building 1, Room 260B,
Bethesda, MD 20892,
KAWAZOER@MAIL.NIH.GOV.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council
of Council’s home page at https://
dpcpsi.nih.gov/council/. Where an agenda
and proposals to be discussed will be posted
before the meeting date.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: January 5, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–381 Filed 1–10–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review: Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
1699
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Brain Injury and Neurovascular
Pathologies Study Section.
Date: February 9–10, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington, DC
Dupont Circle Hotel, 1143 New Hampshire
Avenue NW., Washington, DC 20037.
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892, (301) 435–
1254, yakovleva@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review Group;
Gastrointestinal Mucosal Pathobiology Study
Section.
Date: February 9–10, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Peter J Perrin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroplasticity and
Neurotransmitters Study Section.
Date: February 9–10, 2012.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue NW., Washington, DC 20037.
Contact Person: Suzan Nadi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5217B,
MSC 7846, Bethesda, MD 20892, (301) 435–
1259, nadis@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiological Basis of Mental
Disorders and Addictions Study Section.
Date: February 9–10, 2012.
Time: 8 a.m. to 5 p.m..
Agenda: To review and evaluate grant
applications.
Place: Hilton—Long Beach, 701 West
Ocean Boulevard, Long Beach, CA 90831.
Contact Person: Julius Cinque, MS,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5186,
MSC 7846, Bethesda, MD 20892, (301) 435–
1252, cinquej@csr.nih.gov.
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 77, Number 7 (Wednesday, January 11, 2012)]
[Notices]
[Pages 1697-1699]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-396]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Indian Health Service
Agency Information Collection Activities: Fast Track Generic
Clearance for the Collection of Qualitative Feedback on Agency Service
Delivery: IHS Web Site Customer Service Satisfaction Survey
AGENCY: Indian Health Service, HHS.
ACTION: 30-Day notice of submission of information collection approval
from the Office of Management and Budget (OMB) and request for
comments.
-----------------------------------------------------------------------
[[Page 1698]]
SUMMARY: As part of a Federal Government-wide effort to streamline the
process to seek feedback from the public on service delivery, Indian
Health Service has submitted a Generic Information Collection Request
(Generic ICR): ``Generic Clearance for the Collection of Qualitative
Feedback on Agency Service Delivery'' to OMB for approval under the
Paperwork Reduction Act (PRA) (44 U.S.C. 3501 et seq.).
DATES: Comments must be submitted by February 10, 2012.
ADDRESSES: Send your written comments and suggestions regarding the
proposed information collection contained in this notice, especially
regarding the estimated public burden and associated response time to:
Office of Management and Budget, Office of Regulatory Affairs,
Attention: Desk Officer for IHS, New Executive Office Building, Room
10235, Washington, DC 20503.
Send Requests for Further Information: Requests for more
information on the proposed collection or requests to obtain a copy of
the data collection instrument(s) and instructions may be directed to
Tamara Clay, Acting Reports Clearance Officer, 801 Thompson Avenue,
TMP, Suite 450, Rockville, MD 20852; via non-toll free phone (301) 443-
4750; via facsimile to (301) 443-9879; or via email to
tamara.clay@ihs.gov.
SUPPLEMENTARY INFORMATION:
Title: Generic Clearance for the Collection of Qualitative Feedback
on Agency Service Delivery: IHS Web site Customer Service Satisfaction
Survey.
Abstract: The information collection activity will garner
qualitative customer and stakeholder feedback in an efficient, timely
manner, in accordance with the Administration's commitment to improving
service delivery. By qualitative feedback we mean information that
provides useful insights on perceptions and opinions, but are not
statistical surveys that yield quantitative results that can be
generalized to the population of study. This feedback will provide
insights into customer or stakeholder perceptions, experiences and
expectations, provide an early warning of issues with service, or focus
attention on areas where communication, training or changes in
operations might improve delivery of products or services. These
collections will allow for ongoing, collaborative and actionable
communications between the Agency and its customers and stakeholders.
It will also allow feedback to contribute directly to the improvement
of program management.
Feedback collected under this generic clearance will provide useful
information, but it will not yield data that can be generalized to the
overall population. This type of generic clearance for qualitative
information will not be used for quantitative information collections
that are designed to yield reliably actionable results, such as
monitoring trends over time or documenting program performance. Such
data uses require more rigorous designs that address: The target
population to which generalizations will be made, the sampling frame,
the sample design (including stratification and clustering), the
precision requirements or power calculations that justify the proposed
sample size, the expected response rate, methods for assessing
potential non-response bias, the protocols for data collection, and any
testing procedures that were or will be undertaken prior fielding the
study. Depending on the degree of influence the results are likely to
have, such collections may still be eligible for submission for other
generic mechanisms that are designed to yield quantitative results.
In the Federal Register Notice of December 22, 2010 (75 FR 80542),
OMB published a 60-day notice requesting public comment on the proposed
collection of information. The Agency received zero (0) comments in
response to the 60 day notice. Below we provide Indian Health Service's
projected annual average estimates for the next three years: \1\
---------------------------------------------------------------------------
\1\ The 60-day notice included the following estimate of the
aggregate burden hours for this generic clearance federal-wide:
Average Expected Annual Number of activities: 25,000.
Average number of Respondents per Activity: 200.
Annual Responses: 5,000,000.
Frequency of Response: Once per request.
Average minutes per response: 30.
Burden hours: 2,500,000.
---------------------------------------------------------------------------
Current Actions: New collection of Information.
Type of Review: New Collection.
Affected Public: Individuals and Households, Businesses and
Organizations, State, Local or Tribal Government.
Average Expected Annual Number of Activities: 1.
Respondents: 500.
Annual Responses: 500.
Frequency of Response: Once per request.
Average Minutes per Response: 15 minutes.
Burden Hours: 125 hours.
IHS estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of collection Number of responses per per response Total hours
respondents respondent (in hours) \2\
----------------------------------------------------------------------------------------------------------------
Web site Customer satisfaction survey (web- 500 1 15/60 125
based).........................................
---------------------------------------------------------------
Total....................................... 500 1 15/60 125
----------------------------------------------------------------------------------------------------------------
[[Page 1699]]
An agency may not conduct or sponsor, and a person is not required
to respond to, a collection of information unless it displays a
currently valid OMB control number.
---------------------------------------------------------------------------
\2\ Burden estimates of less than one hour are expressed as a
fraction of an hour in the format ``[number of minutes per
response]/60''.
---------------------------------------------------------------------------
Comment Due Date: Your comments regarding this information
collection are best assured of having full effect if received within 30
days of the date of this publication.
Dated: December 11, 2011.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2012-396 Filed 1-10-12; 8:45 am]
BILLING CODE 4165-16-P
